S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Teladoc Health Stock Forecast, Price & News

$109.61
+3.61 (+3.41%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$109.06
$119.98
50-Day Range
$103.23
$154.29
52-Week Range
$100.51
$308.00
Volume
5.71 million shs
Average Volume
3.06 million shs
Market Capitalization
$17.55 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.33
30 days | 90 days | 365 days | Advanced Chart
Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.


Teladoc Health logo

About Teladoc Health

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002 by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Headlines

Teladoc Health (NYSE:TDOC) Shares Gap Up to $106.00
November 26, 2021 |  americanbankingnews.com
Better Buy: Teladoc vs. Moderna
November 26, 2021 |  finance.yahoo.com
Teladoc Health's (TDOC) Buy Rating Reaffirmed at Berenberg Bank
November 22, 2021 |  americanbankingnews.com
Teladoc Stock: Bull vs. Bear
November 21, 2021 |  nasdaq.com
Teladoc (TDOC) Falls 8.1% Despite Upbeat Revenue Guidance
November 19, 2021 |  finance.yahoo.com
Teladoc Health (NYSE:TDOC) PT Lowered to $135.00
November 19, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
4,400
Year Founded
2002

Sales & Book Value

Annual Sales
$1.09 billion
Cash Flow
$0.12 per share
Book Value
$99.87 per share

Profitability

Net Income
$-485.14 million
Pretax Margin
-43.15%

Debt

Price-To-Earnings

Miscellaneous

Free Float
149,729,000
Market Cap
$17.55 billion
Optionable
Optionable

Company Calendar

Last Earnings
10/27/2021
Today
11/27/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/23/2022

Social Links


MarketRank

Overall MarketRank

2.41 out of 5 stars

Medical Sector

166th out of 1,392 stocks

Offices & Clinics Of Medical Doctors Industry

3rd out of 12 stocks

Analyst Opinion: 4.3Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -












Teladoc Health (NYSE:TDOC) Frequently Asked Questions

Is Teladoc Health a buy right now?

28 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last twelve months. There are currently 14 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Teladoc Health stock.
View analyst ratings for Teladoc Health
or view top-rated stocks.

How has Teladoc Health's stock price been impacted by COVID-19 (Coronavirus)?

Teladoc Health's stock was trading at $137.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TDOC shares have decreased by 20.2% and is now trading at $109.61.
View which stocks have been most impacted by COVID-19
.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Teladoc Health
.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) released its quarterly earnings data on Wednesday, October, 27th. The health services provider reported ($0.53) EPS for the quarter, beating the consensus estimate of ($0.70) by $0.17. The health services provider had revenue of $521.70 million for the quarter, compared to the consensus estimate of $516.79 million. Teladoc Health had a negative trailing twelve-month return on equity of 1.47% and a negative net margin of 43.60%. The company's quarterly revenue was up 80.6% on a year-over-year basis. During the same period in the previous year, the company earned ($0.13) EPS.
View Teladoc Health's earnings history
.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health issued an update on its FY 2021 earnings guidance on Thursday, November, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.02 billion-$2.03 billion, compared to the consensus revenue estimate of $2.02 billion.

What price target have analysts set for TDOC?

28 Wall Street analysts have issued 12-month price objectives for Teladoc Health's shares. Their forecasts range from $135.00 to $275.00. On average, they expect Teladoc Health's stock price to reach $181.19 in the next year. This suggests a possible upside of 65.3% from the stock's current price.
View analysts' price targets for Teladoc Health
or view top-rated stocks among Wall Street analysts.

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the following people:
  • Jason N. Gorevic, Chief Executive Officer & Director
  • Mala Murthy, Chief Financial Officer (LinkedIn Profile)
  • Jeff Nadler, Chief Information Officer
  • Lewis Levy, Chief Medical Officer
  • Claus Ingar Jensen, Chief Innovation Officer

What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health CEO Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among Teladoc Health's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), Shopify (SHOP), DocuSign (DOCU), salesforce.com (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (5.53%), Sumitomo Mitsui Trust Holdings Inc. (4.90%), Nikko Asset Management Americas Inc. (4.63%), Capital World Investors (3.57%), Citadel Advisors LLC (0.00%) and General Catalyst Group Management LLC (1.68%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David Travers, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Sandra L Fenwick, Stephany Verstraete, William H Frist and Yulun Wang.
View institutional ownership trends for Teladoc Health
.

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Aviva PLC, General Catalyst Group Management LLC, Aequim Alternative Investments LP, American Century Companies Inc., Credit Suisse AG, PEAK6 Investments LLC, and California Public Employees Retirement System. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David Travers, David William Sides, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Mala Murthy, Sandra L Fenwick, Stephany Verstraete, and Yulun Wang.
View insider buying and selling activity for Teladoc Health
or view top insider-selling stocks.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was bought by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., Sumitomo Mitsui Trust Holdings Inc., Citadel Advisors LLC, SG Americas Securities LLC, Capital Fund Management S.A., Natixis, Baillie Gifford & Co., and Squarepoint Ops LLC.
View insider buying and selling activity for Teladoc Health
or or view top insider-buying stocks.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $109.61.

How much money does Teladoc Health make?

Teladoc Health has a market capitalization of $17.55 billion and generates $1.09 billion in revenue each year. The health services provider earns $-485.14 million in net income (profit) each year or ($5.77) on an earnings per share basis.

How many employees does Teladoc Health have?

Teladoc Health employs 4,400 workers across the globe.

Does Teladoc Health have any subsidiaries?

The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..

When was Teladoc Health founded?

Teladoc Health was founded in 2002.

What is Teladoc Health's official website?

The official website for Teladoc Health is www.teladochealth.com.

Where are Teladoc Health's headquarters?

Teladoc Health is headquartered at 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at (203) 635-2002 or via email at [email protected].


This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.